202
Participants
Start Date
December 13, 2017
Primary Completion Date
December 22, 2021
Study Completion Date
November 13, 2023
DETOUR System
The DETOUR System is intended to improve blood flow in patients with peripheral arterial disease in symptomatic femoropopliteal lesions due to chronic total occlusions ≥ 20 cm (TASC D) that can include de novo, restenotic, or in-stent restenotic lesions; or total lesion lengths ≥24 cm that can include chronic total occlusions or a ≥70% lesion that includes de novo, restenotic or in-stent restenosis (complex TASC C).
Pauls Stradins Clinical University Hospital, Riga
New York-Presbyterian / Columbia University Medical Center, New York
MedStar Health Research Institute, Hyattsville
Sentara Norfolk General Hospital, Norfolk
North Caroline Hearth and Vascular- University of North Carolina Rex, Raleigh
Greenville Health System, Greenville
First Coast Cardiovascular Institute, Jacksonville
Baptist Hospital Miami, Miami
Cardiology Associates of North Mississippi, Tupelo
Cleveland Clinical Foundation, Cleveland
The Christ Hospital - The Carl & Edyth Lindner Center for Research & Education, Cincinnati
McLaren Bay Region Hospital, Bay City
Advanced Cardiac and Vascular Amputation Prevention Centers, Grandville
Cardiac & Vascular Research Center of Nothern Michigan, Petoskey
Aurora Research Institute, Milwaukee
Klinikum Hochsauerland GmbH, Arnsberg
AMITA Health Alexian Brothers Medical Center, Elk Grove Village
Christie Clinic, Champaign
Prairie Education and Research Cooperative, Springfield
Arkansas Heart Hospital, Little Rock
St. Bernard's Medical Center, Jonesboro
North Dallas Research Associates, Dallas
Texas Tech, Lubbock
Denver VA Medical Center, Denver
HonorHealth, Scottsdale
New Mexico Heart Institute, Albuquerque
Community Hospital of the Monterrey Peninsula, Monterey
Bay Area Vein and Vascular, Burlingame
Advanced Cardiovascular Specialists, Mountain View
The Vascular Experts, Darien
Massachusetts General Hospital, Boston
Miriam Hospital, Providence
Cardioangiologisches Centrum Bethanien, Frankfurt
Universität Leipzig, Leipzig
Lead Sponsor
Endologix
INDUSTRY